Seeking Alpha: Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma
The VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay is the first clinically approved in-situ hybridisation (ISH) test with the sensitivity to assess the full spectrum of B-cell lymphoma ...
Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma
technologynetworks: Arima Genomics Introduces Aventa Lymphoma Test To Resolve Diagnostic Uncertainty in B- and T-Cell Lymphomas
Arima Genomics, Inc., announced the broad commercial launch of the Aventa Lymphoma test at the Society of Hematologic Oncology (SOHO 2025) meeting in Houston, Texas. Offered through the CLIA-certified ...
Arima Genomics Introduces Aventa Lymphoma Test To Resolve Diagnostic Uncertainty in B- and T-Cell Lymphomas
EurekAlert!: New ultra-sensitive DNA blood test for detecting residual cancer in B-cell lymphoma patients
New ultra-sensitive DNA blood test for detecting residual cancer in B-cell lymphoma patients
The Foresight CLARITY test offers greater prognostic accuracy than PET/CT scans in large B-cell lymphoma by detecting ctDNA-MRD negativity, indicating better patient outcomes. ctDNA-MRD testing showed ...
Determining the presence of mantle cell lymphoma involves a physical examination, microscopic analysis, genetic screening, and specialized antigen tests. Your body’s lymphatic system is made up of ...
This overview describes current information on the types of tests used to detect SARS-CoV-2 infection and their intended uses. This information is intended for use by healthcare providers, public health professionals, and those organizing and implementing testing in non-healthcare settings.
Background Healthcare providers use test results to diagnose disease, determine prognosis, and monitor a patient’s treatment or health status.